110 related articles for article (PubMed ID: 9445156)
1. Double-phase Tc-99m-SestaMIBI SPECT imaging in a case of glomus jugulare tumor.
Kostakoglu L; Elahi N; Uzal D; Khademi B; Atahan L; Bekdik CF
Radiat Med; 1997; 15(5):331-4. PubMed ID: 9445156
[TBL] [Abstract][Full Text] [Related]
2. Prospective Evaluation of (99m)Tc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors.
Gorin MA; Rowe SP; Baras AS; Solnes LB; Ball MW; Pierorazio PM; Pavlovich CP; Epstein JI; Javadi MS; Allaf ME
Eur Urol; 2016 Mar; 69(3):413-6. PubMed ID: 26386607
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness Analysis of
Su ZT; Patel HD; Huang MM; Meyer AR; Pavlovich CP; Pierorazio PM; Javadi MS; Allaf ME; Rowe SP; Gorin MA
Eur Urol Focus; 2021 Jul; 7(4):827-834. PubMed ID: 32115400
[TBL] [Abstract][Full Text] [Related]
4. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99 m-sestamibi single-photon emission computerised tomography (CT)/CT in the prediction of malignant versus benign small renal masses.
Viswambaram P; Swarbrick N; Picardo A; Hohnen A; Pham K; Macdonald W; Hayne D; Hamid A
BJU Int; 2022 Nov; 130 Suppl 3():23-31. PubMed ID: 35365966
[TBL] [Abstract][Full Text] [Related]
6. Protocol for a MULTI-centre feasibility study to assess the use of
Warren H; Wagner T; Gorin MA; Rowe S; Holman BF; Pencharz D; El-Sheikh S; Barod R; Patki P; Mumtaz F; Bex A; Kasivisvanathan V; Moore CM; Campain N; Cartledge J; Scarsbrook A; Hassan F; O'Brien TS; Stewart GD; Mendichovszky I; Dizdarevic S; Alanbuki A; Wildgoose WH; Wah T; Vindrola-Padros C; Pizzo E; Dehbi HM; Lorgelly P; Gurusamy K; Emberton M; Tran MGB
BMJ Open; 2023 Jan; 13(1):e067496. PubMed ID: 36693694
[TBL] [Abstract][Full Text] [Related]
7.
Tzortzakakis A; Papathomas T; Gustafsson O; Gabrielson S; Trpkov K; Ekström-Ehn L; Arvanitis A; Holstensson M; Karlsson M; Kokaraki G; Axelsson R
Scand J Urol; 2022; 56(5-6):375-382. PubMed ID: 36065481
[TBL] [Abstract][Full Text] [Related]
8. Clinical Performance of Technetium-99m-Sestamibi SPECT/CT Imaging in Differentiating Oncocytic Tumors From Renal Cell Carcinoma in Routine Clinical Practice.
Schober JP; Braun A; Ginsburg KB; Bell S; Castro Bigalli AA; Chen M; Wang R; Magee D; Bukavina L; Handorf E; Yu JQ; Chen DYT; Greenberg RE; Smaldone MC; Viterbo R; Correa AF; Uzzo RG; Kutikov A
J Urol; 2023 Sep; 210(3):438-445. PubMed ID: 37378576
[TBL] [Abstract][Full Text] [Related]
9. The Role of
Basile G; Fallara G; Verri P; Uleri A; Chiti A; Gianolli L; Pepe G; Tedde A; Algaba F; Territo A; Sanguedolce F; Larcher A; Gallioli A; Palou J; Montorsi F; Capitanio U; Breda A
Eur Urol; 2024 Jan; 85(1):63-71. PubMed ID: 37673752
[TBL] [Abstract][Full Text] [Related]
10. Preoperative 123I/99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism.
Neumann DR; Obuchowski NA; Difilippo FP
J Nucl Med; 2008 Dec; 49(12):2012-7. PubMed ID: 18997051
[TBL] [Abstract][Full Text] [Related]
11. Tc99m-sestamibi thigh SPECT/CT images for noninvasive assessment of skeletal muscle injury in carbon monoxide intoxication with clinical and pathological correlation.
Huang SH; Chang WN; Chen SF; Wang PW; Lui CC; Tu MC; Lee CC; Huang YC; Hung BT; Chen SW; Chang CC
Clin Nucl Med; 2011 Mar; 36(3):199-205. PubMed ID: 21285677
[TBL] [Abstract][Full Text] [Related]
12.
Campbell SP; Tzortzakakis A; Javadi MS; Karlsson M; Solnes LB; Axelsson R; Allaf ME; Gorin MA; Rowe SP
Br J Radiol; 2018 Apr; 91(1084):20170526. PubMed ID: 29271233
[TBL] [Abstract][Full Text] [Related]
13. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
14. Visualisation of a paraganglioma by technetium-99m-sestamibi scintigraphy.
Piga M; Farina GP; Loi GL; Serra A; Calia MA; Lai L; Zucca G; Mariotti S
J Endocrinol Invest; 1999 Apr; 22(4):296-300. PubMed ID: 10342364
[TBL] [Abstract][Full Text] [Related]
15. Use of quantitative SPECT/CT reconstruction in
Jones KM; Solnes LB; Rowe SP; Gorin MA; Sheikhbahaei S; Fung G; Frey EC; Allaf ME; Du Y; Javadi MS
Ann Nucl Med; 2018 Feb; 32(2):87-93. PubMed ID: 29214562
[TBL] [Abstract][Full Text] [Related]
16. Assessment of 99mTc-MIBI SPECT(/CT) to monitor multidrug resistance-related proteins and apoptosis-related proteins in patients with ovarian cancer: a preliminary study.
Kurata S; Ushijima K; Kawahara A; Kaida H; Kawano K; Hirose Y; Kage M; Kamura T; Ishibashi M; Abe T
Ann Nucl Med; 2015 Aug; 29(7):643-9. PubMed ID: 25921216
[TBL] [Abstract][Full Text] [Related]
17. Discordant technetium-99m-MIBI and technetium-99m-HMPAO uptake of recurrent occipital meningioma on brain SPECT images.
Shih WJ; Lee JK; Milan P
J Nucl Med; 1996 Jul; 37(7):1183-5. PubMed ID: 8965195
[TBL] [Abstract][Full Text] [Related]
18. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography.
Berman DS; Hachamovitch R; Kiat H; Cohen I; Cabico JA; Wang FP; Friedman JD; Germano G; Van Train K; Diamond GA
J Am Coll Cardiol; 1995 Sep; 26(3):639-47. PubMed ID: 7642853
[TBL] [Abstract][Full Text] [Related]
19. Tc-99m sestamibi uptake by malignant lymphoma and slow washout.
Matsui R; Komori T; Narabayashi I; Namba R; Nakata Y; Tabuchi K; Adachi I; Tatu Y; Shimizu T; Sueyoshi K
Clin Nucl Med; 1995 Apr; 20(4):352-6. PubMed ID: 7788994
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 99mTc-sestamibi and 11C-methionine PET/CT in the localization of parathyroid adenomas in primary hyperparathyroidism.
Martínez-Rodríguez I; Martínez-Amador N; de Arcocha-Torres M; Quirce R; Ortega-Nava F; Ibáñez-Bravo S; Lavado-Pérez C; Bravo-Ferrer Z; Carril JM
Rev Esp Med Nucl Imagen Mol; 2014; 33(2):93-8. PubMed ID: 24125595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
